CD38-NAD+-Sirt1 axis in T cell immunotherapy.

Aging 2020
Open on PubMed

Epub 2019 Oct 23. CD38-NAD(+)-Sirt1 axis in T cell immunotherapy. Chatterjee S(1), Chakraborty P(2), Mehrotra S(2).